A federal judge has dismissed a $600 million antitrust lawsuit filed by former Los Angeles Clippers owner Donald Sterling against the NBA and his wife Shelly Sterling.
In the Tuesday order, US District Judge Fernando M. Olguin said he was “skeptical Sterling suffered any injury at all, let alone an antitrust injury” by the sale of the team for $2 billion to ex-Microsoft CEO Steve Ballmer and called other parts of the lawsuit implausible.
Donald Sterling, 81, had claimed in the lawsuit that he could have got more than that for the team but the circumstances of the sale “markedly reduced” the price.
Shelly Sterling’s attorney Pierce O’Donnell said in a statement that the dismissal “puts a merciful end to his quixotic litigation campaign over the sale for the record-shattering price of $2 billion.”
O’Donnell added that, “Ironically, Donald, in defeat, is the beneficiary of $2 billion, secured by Shelley in her courageous battle in doing the right thing to protect her family and ensure that her beloved team would be sold to a conscientious owner who would take the team to the next level of excellence.”
Donald Sterling’s attorneys did not immediately respond to a request for comment. The NBA declined to comment.
Full Content: Chicago Tribune
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas